| Ytd | 60.17% | |
| 1y | 32.48% |
| Open | 5.67 | Prev Close | 5.67 | Low | 5.67 | High | 5.67 | Mkt Cap | 302.20M |
| Vol | 10.90M | Avg Vol | 1.45M | EPS | -1.81 | P/E | -3.13 | Forward P/E | -4.68 |
| Beta | 0.31 | Short Ratio | 11.41 | Inst. Own | 81.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.34 | 200-d Avg | 3.86 | 1yr Est | 17.50 |
SCPH News
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest
MONSEY, N.Y., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating scPharmaceuticals (NASDAQ: SCPH) for pos
DANBURY, Conn. and BURLINGTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq
BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Com
scPharmaceuticals Inc. (NASDAQ:SCPH ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Com
scPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Co
Generated net FUROSCIX ® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharma
scPharmaceuticals (SCPH) witnessed a jump in share price last session on above-average trading volum
Shares of scPharmaceuticals have lost 37% over the past 3 years and are down 11% in 2025. Furoscix's
scPharmaceuticals Inc. (NASDAQ:SCPH ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Compa
ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.34 per share versus the Zacks Co
Generated net FUROSCIX ® revenue of $11.8 million in the first quarter of 2025 Formally launched FUR
Management to host conference call and webcast, after-market on May 14, 2025, at 4:30 p.m. ET Manage
BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Comp
scPharmaceuticals Inc. (NASDAQ:SCPH ) Q4 2024 Results Conference Call March 19, 2025 4:30 PM ET Comp
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn
Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earni
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesda
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Tuesday
Stocks Which Set New 52-Week Lows Friday